ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
0.9902
+0.0801 (8.80%)
Apr 24, 2025, 4:00 PM EDT - Market closed
ProKidney Stock Forecast
PROK's stock price has decreased by -60.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ProKidney stock have an average target of 5.00, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 404.95% from the current stock price of 0.99.
Analyst Consensus: Buy
* Price targets were last updated on Sep 10, 2024.
Analyst Ratings
The average analyst rating for ProKidney stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +505.94% | Sep 10, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +202.97% | Sep 4, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +505.94% | Jun 10, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +303.96% | May 29, 2024 |
Financial Forecast
Revenue This Year
n/a
from 76.00K
Revenue Next Year
n/a
EPS This Year
-0.61
from -0.62
EPS Next Year
-0.61
from -0.61
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.55 | -0.48 | -0.49 | ||
| Avg | -0.61 | -0.61 | -0.70 | ||
| Low | -0.71 | -0.80 | -0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.